Bal, T. Et Al. 2020. Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity. Turkish Journal of Biochemistry , vol.46, no.1 , 21-26.

Bal, T., DOĞAN, S., ÇABALAK, M., & DİRİCAN, E., (2020). Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity. Turkish Journal of Biochemistry , vol.46, no.1, 21-26.

Bal, Tayibe Et Al. "Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity," Turkish Journal of Biochemistry , vol.46, no.1, 21-26, 2020

Bal, Tayibe Et Al. "Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity." Turkish Journal of Biochemistry , vol.46, no.1, pp.21-26, 2020

Bal, T. Et Al. (2020) . "Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity." Turkish Journal of Biochemistry , vol.46, no.1, pp.21-26.

@article{article, author={Tayibe Bal Et Al. }, title={Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity}, journal={Turkish Journal of Biochemistry}, year=2020, pages={21-26} }